Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 33 citing articles:

Novel viral vectors in infectious diseases
Ian R. Humphreys, Sarah Sebastian
Immunology (2017) Vol. 153, Iss. 1, pp. 1-9
Open Access | Times Cited: 140
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Imaging of intranasal drug delivery to the brain.
Michael C. Veronesi, Mosa Alhamami, Shelby B Miedema, et al.
PubMed (2020) Vol. 10, Iss. 1, pp. 1-31
Closed Access | Times Cited: 64
Novel prime-boost vaccine strategies against HIV-1
Jean‐Louis Excler, Jérôme H. Kim
Expert Review of Vaccines (2019) Vol. 18, Iss. 8, pp. 765-779
Closed Access | Times Cited: 43
Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection
Sandra González, Natalia A. Taborda, Marı́a Teresa Rugeles
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 46
Preventive effect of bergenin against the development of TNBS-induced acute colitis in rats is associated with inflammatory mediators inhibition and NLRP3/ASC inflammasome signaling pathways
Guilherme Antônio Lopes de Oliveira, Catalina Alarcón‐de‐la‐Lastra, María Ángeles Rosillo, et al.
Chemico-Biological Interactions (2018) Vol. 297, pp. 25-33
Closed Access | Times Cited: 40
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
Amy S. Espeseth, Maoli Yuan, Michael Citron, et al.
EBioMedicine (2022) Vol. 82, pp. 104203-104203
Open Access | Times Cited: 19
Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years
Carolina Souza Santana, Felipe de Oliveira Andrade, Greice Carolina Santos da Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis
Siamak Haddadi, Niroshan Thanthrige-Don, Sam Afkhami, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys
Enxiang Pan, Fengling Feng, Pingchao Li, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 29
The Challenges of Vaccine Development against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector
T. A. Zaichuk, Yury D. Nechipurenko, A. A. Adzhubey, et al.
Molecular Biology (2020) Vol. 54, Iss. 6, pp. 812-826
Open Access | Times Cited: 24
Lessons for general vaccinology research from attempts to develop an HIV vaccine
Stuart Z. Shapiro
Vaccine (2019) Vol. 37, Iss. 26, pp. 3400-3408
Closed Access | Times Cited: 16
The use of adenoviral vectors in gene therapy and vaccine approaches
Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, et al.
Genetics and Molecular Biology (2022) Vol. 45, Iss. 3 suppl 1
Open Access | Times Cited: 9
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
Christopher L. Cooper, Gavin Morrow, Maoli Yuan, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1582-1582
Open Access | Times Cited: 8
Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1
Danushka K. Wijesundara, Charani Ranasinghe, Branka Grubor‐Bauk, et al.
Frontiers in Microbiology (2017) Vol. 8
Open Access | Times Cited: 14
Novel Concepts for HIV Vaccine Vector Design
Quazim A. Alayo, Nicholas M. Provine, Pablo Penaloza‐MacMaster
mSphere (2017) Vol. 2, Iss. 6
Open Access | Times Cited: 11
Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo
Richard Kiener, M. Fleischmann, Christiane Schwegler, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 11
T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
Z. Zhang, Maozhou He, Shimeng Bai, et al.
Viruses (2018) Vol. 10, Iss. 12, pp. 667-667
Open Access | Times Cited: 9
Heterologous prime-boost regimens with HAdV-5 and NDV vectors elicit stronger immune responses to Ebola virus than homologous regimens in mice
Wei Zhao, Peng Zhang, Shuang Bai, et al.
Archives of Virology (2021) Vol. 166, Iss. 12, pp. 3333-3341
Open Access | Times Cited: 8
Sendai virus particles carrying target virus glycoproteins for antibody induction
Hiroshi Ishii, Midori Nakamura‐Hoshi, Tsugumine Shu, et al.
Vaccine (2022) Vol. 40, Iss. 16, pp. 2420-2431
Open Access | Times Cited: 5
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
O. V. Matveeva, Svetlana A. Shabalina
Cancers (2020) Vol. 12, Iss. 12, pp. 3659-3659
Open Access | Times Cited: 7
Therapeutic vaccine-mediated Gag-specific CD8+ T-cell induction under anti-retroviral therapy augments anti-virus efficacy of CD8+ cells in simian immunodeficiency virus-infected macaques
Midori Nakamura‐Hoshi, Yusuke Takahara, Saori Matsuoka, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 6
A D-peptide-based HIV gelatinous combination vaccine improves therapy in ART-delayed macaques of chronic infection
Ye Liu, Xiaolin Ji, Ying Liu, et al.
Nano Today (2021) Vol. 42, pp. 101353-101353
Open Access | Times Cited: 6
A Novel Immunogen Selectively Eliciting CD8 + T Cells but Not CD4 + T Cells Targeting Immunodeficiency Virus Antigens
Hiroshi Ishii, Kazutaka Terahara, Takushi Nomura, et al.
Journal of Virology (2020) Vol. 94, Iss. 8
Open Access | Times Cited: 5
A Zigzag but Upward Way to Develop an HIV-1 Vaccine
Ziyu Wen, Caijun Sun
Vaccines (2020) Vol. 8, Iss. 3, pp. 511-511
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top